首页> 美国卫生研究院文献>Journal of Nucleic Acids >Expression of O6-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients
【2h】

Expression of O6-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients

机译:O6-烷基鸟嘌呤-DNA烷基转移酶在埃及患者正常和恶性膀胱组织中的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bladder tumour tissues and corresponding uninvolved mucosa (normal tissue) of Egyptian bladder cancer patients were assessed for O6-alkylguanine-DNA-alkyltransferase (MGMT) activity by functional assay of tissue extracts (36 paired samples), and distribution by immunofluorescence (IF) microscopy of fixed material (24 paired samples). MGMT varied widely from 42–253 fmoles/mg protein and from 3.2–40 fmoles/μg DNA in normal and 58–468 fmoles/mg protein and 2.5–49.5 fmoles/mg protein, in the tumour tissues; only one tumour had undetectable activity. Pairwise comparison of MGMT activity in tumour and adjacent normal tissue showed no significant difference based on DNA content but was 1.75-fold higher in tumour (P < .01) based on protein. There was no effect of gender or bilharzia infection status. IF showed that in tumours, both the mean percentage of positive nuclei (57.3 ± 20.3%) and mean integrated IF (5.47 ± 3.66) were significantly higher than those in uninvolved tissues (42.8± 13.5% P = .04) and (1.89 ± 1.42; P < .01), respectively. These observationssuggest that, overall, MGMT levels are increased during humanbladder carcinogenesis and that MGMT downregulation is not acommon feature of bladder cancers. Based on this, bladder cancerswould be expected to be relatively resistant to chemotherapy whichinvolved O6-guanine alkylating antitumour agents.
机译:通过组织提取物的功能测定(36个配对样品)评估了埃及膀胱癌患者的膀胱肿瘤组织和相应的未累及的粘膜(正常组织)的O 6 -烷基鸟嘌呤-DNA-烷基转移酶(MGMT)活性,固定材料(24个配对样品)的免疫荧光(IF)显微镜观察和分布。 MGMT在正常组织中差异很大,从42–253 fmoles / mg蛋白和3.2–40 fmoles /μgDNA,在肿瘤组织中从58–468 fmoles / mg蛋白和2.5–49.5 fmoles / mg蛋白变化很大。只有一个肿瘤具有不可检测的活性。肿瘤和邻近正常组织中MGMT活性的成对比较显示,基于DNA含量无明显差异,但基于蛋白质,在肿瘤中MGMT活性高1.75倍(P <.01)。性别或双性恋感染状态没有影响。 IF显示,在肿瘤中,阳性细胞核的平均百分比(57.3±20.3%)和平均整合IF(5.47±3.66)均显着高于未受累的组织(42.8)±13.5%P = .04)和(1.89±1.42; P <.01)。这些观察提示,总体而言,MGMT水平在人类膀胱癌的发生和MGMT下调不是膀胱癌的共同特征。基于此,膀胱癌可以预期对化疗具有相对抗性涉及O 6 -鸟嘌呤烷基化抗肿瘤药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号